Cassava Sciences reported $-0.26 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cassava Sciences USD -0.26 0.04 Dec/2025
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Geron USD -0.01 0.04 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025